Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LUKAKLINE CHEWABLE TABLET 4MG - HSA Drug Approval Details

Approvals/HSA/LUKAKLINE CHEWABLE TABLET 4MG

Approved

THERAPEUTIC

LUKAKLINE CHEWABLE TABLET 4MG

DR. REDDY&#x27S LABORATORIES LIMITED FTO-III (INDIA)🇸🇬 Health Sciences Authority

Approval Date: Mar 21, 2013
Approval ID: 029d64a8f195aef5
Company: DR. REDDY&#x27S LABORATORIES LIMITED FTO-III (INDIA)
Type: Therapeutic

Approval Details

Approval Id: 029d64a8f195aef5
Drug Name: LUKAKLINE CHEWABLE TABLET 4MG
Product Name: LUKAKLINE CHEWABLE TABLET 4MG
Approval Number: SIN14330P
Approval Date: 2013-03-21
Registrant: ZYFAS PHARMA PTE LTD
Licence Holder: ZYFAS PHARMA PTE LTD
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: TABLET, CHEWABLE
Route Of Administration: ORAL
Atc Code: R03DC03
Atc Item Name: montelukast
Pharma Manufacturer Name: ZYFAS PHARMA PTE. LTD.
Company Detail Path: /organization/zyfas-pharma-pte-ltd

Active Ingredients

Montelukast sodium 4.16mg eqv. Montelukast

4 mg

MONTELUKAST SODIUM 4.16 MG EQV. MONTELUKAST

4 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Mar 21, 2013

Approval ID

029d64a8f195aef5

Type

Therapeutic

Back to HSA Approvals